BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 26100984)

  • 1. Dysregulated transcription across diverse cancer types reveals the importance of RNA-binding protein in carcinogenesis.
    Wang J; Liu Q; Shyr Y
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S5. PubMed ID: 26100984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive expression landscape of RNA-binding proteins (RBPs) across 16 human cancer types.
    Zhang B; Babu KR; Lim CY; Kwok ZH; Li J; Zhou S; Yang H; Tay Y
    RNA Biol; 2020 Feb; 17(2):211-226. PubMed ID: 31607220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational landscape of RNA-binding proteins in human cancers.
    Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
    RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of post-transcriptional regulation during cancer progression using a donor-derived isogenic model of tumorigenesis.
    Bisogno LS; Keene JD
    Methods; 2017 Aug; 126():193-200. PubMed ID: 28529064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAPKAPK2: the master regulator of RNA-binding proteins modulates transcript stability and tumor progression.
    Soni S; Anand P; Padwad YS
    J Exp Clin Cancer Res; 2019 Mar; 38(1):121. PubMed ID: 30850014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis.
    Simmonds P; Loomis E; Curry E
    Genome Med; 2017 Jun; 9(1):54. PubMed ID: 28592290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive in silico expression analysis of RNA binding proteins in normal and tumor tissue: Identification of potential players in tumor formation.
    Galante PA; Sandhu D; de Sousa Abreu R; Gradassi M; Slager N; Vogel C; de Souza SJ; Penalva LO
    RNA Biol; 2009; 6(4):426-33. PubMed ID: 19458496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of transcription factors and targets co-expression profiles reveals reduced correlation between transcription factors and target genes in cancer.
    Liang J; Cui Y; Meng Y; Li X; Wang X; Liu W; Huang L; Du H
    Funct Integr Genomics; 2019 Jan; 19(1):191-204. PubMed ID: 30251028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.
    Peng L; Bian XW; Li DK; Xu C; Wang GM; Xia QY; Xiong Q
    Sci Rep; 2015 Aug; 5():13413. PubMed ID: 26292924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in Eukaryotic Elongation Factor complex proteins (EEF1s) in cancer and their implications in epigenetic regulation.
    Biterge-Sut B
    Life Sci; 2019 Dec; 238():116977. PubMed ID: 31639400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TF-RBP-AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers.
    He M; Hu F
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inferring RBP-Mediated Regulation in Lung Squamous Cell Carcinoma.
    Lafzi A; Kazan H
    PLoS One; 2016; 11(5):e0155354. PubMed ID: 27186987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional landscape of human cancers.
    Li M; Sun Q; Wang X
    Oncotarget; 2017 May; 8(21):34534-34551. PubMed ID: 28427185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-Binding Proteins as Important Regulators of Long Non-Coding RNAs in Cancer.
    Jonas K; Calin GA; Pichler M
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Genomic Characterization of RNA-Binding Proteins across Human Cancers.
    Wang ZL; Li B; Luo YX; Lin Q; Liu SR; Zhang XQ; Zhou H; Yang JH; Qu LH
    Cell Rep; 2018 Jan; 22(1):286-298. PubMed ID: 29298429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the expression landscape of RNA-binding proteins in human cancers.
    Kechavarzi B; Janga SC
    Genome Biol; 2014 Jan; 15(1):R14. PubMed ID: 24410894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic and genetic deregulation in cancer target distinct signaling pathway domains.
    Gao Y; Teschendorff AE
    Nucleic Acids Res; 2017 Jan; 45(2):583-596. PubMed ID: 27899617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-organ transcriptome variation across 21 cancer types.
    Hu W; Yang Y; Li X; Zheng S
    Oncotarget; 2017 Jan; 8(4):6809-6818. PubMed ID: 28036280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncovering RNA binding proteins associated with age and gender during liver maturation.
    Chaturvedi P; Neelamraju Y; Arif W; Kalsotra A; Janga SC
    Sci Rep; 2015 Mar; 5():9512. PubMed ID: 25824884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation and competition by RNA-binding proteins in cancer.
    Nag S; Goswami B; Das Mandal S; Ray PS
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):286-297. PubMed ID: 35248729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.